We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-8.33%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$74.8B
AUM Growth
-$7.83B
(-9.5%)
Cap. Flow
-$682M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
38.47%
Holding
1,074
New
309
Increased
211
Reduced
468
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.51B |
| 2 |
Netflix
NFLX
|
+$1.29B |
| 3 |
Shopify
SHOP
|
+$1.02B |
| 4 |
XYZ
Block Inc
XYZ
|
+$778M |
| 5 |
PayPal
PYPL
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$1.08B |
| 2 |
Cisco
CSCO
|
+$1.04B |
| 3 |
Colgate-Palmolive
CL
|
+$713M |
| 4 |
Automatic Data Processing
ADP
|
+$433M |
| 5 |
Deere & Co
DE
|
+$356M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.61% |
| 2 | Healthcare | 15.4% |
| 3 | Consumer Discretionary | 14.87% |
| 4 | Communication Services | 14.68% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Helen of Troy
HELE
$664M
| $33M | 0.04% |
168,447
+5,345
| +3% | +$1.13M |
|
202
e.l.f. Beauty
ELF
$5.63B
| $32.9M | 0.04% |
1,275,098
-24,323
| -2% | -$662K |
|
|
SYNH
203
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $32.6M | 0.04% |
402,899
-56,032
| -12% | -$4.74M |
|
204
Broadridge
BR
$19.5B
| $32.5M | 0.04% |
208,480
+6,634
| +3% | +$1.02M |
|
205
Planet Fitness
PLNT
$3.71B
| $32.4M | 0.04% |
382,959
+104,260
| +37% | +$9.05M |
|
|
PRMW
206
DELISTED
Primo Water Corporation
PRMW
| $32.2M | 0.04% |
2,257,284
-43,061
| -2% | -$674K |
|
207
Axos Financial
AX
$5.63B
| $32.1M | 0.04% |
692,655
+21,943
| +3% | +$1.16M |
|
208
Valvoline
VVV
$4.34B
| $32M | 0.04% |
1,014,999
-34,299
| -3% | -$1.12M |
|
209
Bio-Techne
TECH
$11.2B
| $31.9M | 0.04% |
295,052
-7,164
| -2% | -$739K |
|
210
Trimble
TRMB
$13.8B
| $31.4M | 0.04% |
434,853
+13,783
| +3% | +$982K |
|
211
Tyler Technologies
TYL
$13B
| $31.3M | 0.04% |
70,390
+2,227
| +3% | +$1M |
|
212
Hexcel
HXL
$7.78B
| $31M | 0.04% |
521,180
+16,535
| +3% | +$912K |
|
213
Endava
DAVA
$155M
| $30.6M | 0.04% |
230,193
+7,305
| +3% | +$920K |
|
214
Floor & Decor
FND
$6.36B
| $30.5M | 0.04% |
376,405
+12,122
| +3% | +$1.23M |
|
215
BioMarin Pharmaceuticals
BMRN
$12.7B
| $30.5M | 0.04% |
395,171
-57,743
| -13% | -$4.83M |
|
216
Itron
ITRI
$4.52B
| $30.4M | 0.04% |
576,944
-11,007
| -2% | -$616K |
|
217
Envista
NVST
$4.53B
| $30.3M | 0.04% |
+622,757
| New | +$28.7M |
|
218
Euronet Worldwide
EEFT
$2.64B
| $30.3M | 0.04% |
232,827
-7,141
| -3% | -$906K |
|
219
iHeartMedia
IHRT
$558M
| $30M | 0.04% |
1,587,311
-9,745
| -0.6% | -$194K |
|
|
SWTX
220
DELISTED
SpringWorks Therapeutics
SWTX
| $30M | 0.04% |
532,164
-10,152
| -2% | -$581K |
|
221
Insmed
INSM
$29B
| $30M | 0.04% |
1,278,093
-24,417
| -2% | -$567K |
|
222
Morgan Stanley
MS
$340B
| $30M | 0.04% |
343,560
-69,051
| -17% | -$6.66M |
|
223
Bristol-Myers Squibb
BMY
$133B
| $29.9M | 0.04% |
409,031
-171,403
| -30% | -$11.5M |
|
224
WEX
WEX
$6.35B
| $29.5M | 0.04% |
165,505
-31,318
| -16% | -$5.11M |
|
|
BWIN
225
Baldwin Insurance Group
BWIN
$2.8B
| $29.4M | 0.04% |
1,097,313
-20,932
| -2% | -$603K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2022 Portfolio in Review
As of Q1 2022, Loomis, Sayles & Company held 1,074 positions worth $74.8B, down 9.5% from $82.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Loomis, Sayles & Company's Q1 2022 filing shows 309 new, 211 increased, 468 reduced and 69 closed positions. Its largest new stake was Doximity: 2,218,936 shares worth $116M. The largest sale was SLB Ltd, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Loomis, Sayles & Company's largest Q1 2022 buy was Doximity: 2,218,936 shares worth $116M.
- Loomis, Sayles & Company added most to Tesla in Q1 2022, an estimated $1.51B increase.
- Loomis, Sayles & Company's biggest Q1 2022 reduction was SLB Ltd, cutting an estimated $1.08B.
- Loomis, Sayles & Company fully exited CryoPort in Q1 2022, selling an estimated $51M.
- Loomis, Sayles & Company's ten largest holdings make up 38% of its $74.8B portfolio in Q1 2022.
- Loomis, Sayles & Company opened 309 new positions and closed 69 in Q1 2022.
- Loomis, Sayles & Company's portfolio value fell 9.5% quarter-over-quarter to $74.8B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2022, filed 13 May 2022.